As MDSCs inhibit antigen-specific CD8+ T cell function and icaritin reduces MDSC number, we hypothesized that T cell function would correspondingly recover in icaritin-treated mice with HCC. This evidence concerns the gene CD8A and hepatocellular carcinoma.